Cervical Dystonia Management Market Size and Growth Rate:
“The Global Cervical Dystonia Management Market was valued at US$ XX Bn in 2018 and is expected to grow at a significant CAGR over six years forecast period 2019-2025 owing to rising elderly population globally”
Cervical Dystonia Management Market Growth Drivers and Restraints:
The global cervical dystonia management market was valued at US$ XX Bn in 2018 and growing at a CAGR of 5.1% over the forecast period owing to rising female population and increasing prevalence of cervical dystonia. According to NORD, in the general population the incidence or prevalence of cervical dystonia is not exactly known but it is estimated to be around 60,000 people in the United States. Moreover, increasing development of healthcare infrastructure and rising awareness among the population is expected to drive the growth of the market. The favorable healthcare reimbursement policies are also expected to fuel the growth of the market. However, high cost of treatment is the major factor that restrains the growth of the market.
Browse More Insights of the report @ https://www.precisionbusinessinsights.com/market-reports/global-cervical-dystonia-management-market/
Hospital pharmacies segment accounted for higher revenue share
Based on distribution channel, global cervical dystonia management market segmented hospital pharmacies, retail pharmacies, and others. Hospital pharmacies segment market accounted US$ XX Mn in 2018 and projected to dominate over the forecast period owing to increasing number of patients visiting hospitals year over year and development of healthcare infrastructure coupled with increasing support from the government. Retail pharmacies are expected to grow with a significant CAGR over the forecast years owing to increasing using of orals.
North America is expected to dominate Global Cervical Dystonia Management Market
PBI’s global cervical dystonia management market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to regional analysis, North America is expected to account for larger revenue share in 2018 and the same trend is projected to follow over 2019-2025 owing to the well-established healthcare infrastructure, rising demand for better treatment for cervical dystonia and increasing support from the government. Moreover, growing elderly population is the major factor driving the growth of the market. Europe and Asia-Pacific Asia Pacific is expected to significant growth rate over the forecast years owing to increasing number of population and rising prevalence of cervical dystonia in the region and growing awareness among the population regarding the available treatment for the cervical dystonia management.
Market Players are focusing on the receiving approvals the drugs for the treatment of Cervical Dystonia Management
Key player’s profiles in the report are ALLERGAN (Ireland), US WorldMeds (U.S.), Ipsen (France), Addex Therapeutics (Switzerland), and Revance Therapeutics Inc. (U.S.).
Avail Sample of the report for more information @ https://www.precisionbusinessinsights.com/request-sample?product_id=15957
Detailed Segmentation of Cervical Dystonia Management Market:
By Product Type
o Dopaminergic drugs
o Anti-cholinergic drugs
o GABA Agonists
o Anti Convulsants
By Dosage Form
o Hospital pharmacies
o Retail pharmacies
o North America
o Latin America
o Middle East and Africa (MEA)
Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights.
Senior Business Development Executive
Email @ [email protected]
Call @ +1-866-598-1553
Precision Business Insights